Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease.
2021
This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
6
References
5
Citations
NaN
KQI